必须声明标量变量 "@Script_ID"。 粪便微生物移植研究现状及其在炎症性肠病中的应用-《赣南医学院学报》

[1]古肖湘,吴雄健.粪便微生物移植研究现状及其在炎症性肠病中的应用[J].赣南医学院学报,2019,39(10):994-998.[doi:10.3969/j.issn.1001-5779.2019.10.005]
 GU Xiao-xiang,WU Xiong-jian.Current status of fecal microbial transplantation and its application in inflammatory bowel disease[J].,2019,39(10):994-998.[doi:10.3969/j.issn.1001-5779.2019.10.005]
点击复制

粪便微生物移植研究现状及其在炎症性肠病中的应用()
分享到:

《赣南医学院学报》[ISSN:1001-5779/CN:36-1154/R]

卷:
39
期数:
2019年10期
页码:
994-998
栏目:
炎症与免疫·基础与临床
出版日期:
2019-11-24

文章信息/Info

Title:
Current status of fecal microbial transplantation and its application in inflammatory bowel disease
文章编号:
1001-5779(2019)10-0994-05
作者:
古肖湘1吴雄健2
赣南医学院 1.2018级硕士研究生; 2.第一附属医院消化内科,江西 赣州 341000
Author(s):
GU Xiao-xiang1 WU Xiong-jian2
Gannan Medical University 1.Postgraduate student of Grade 2018; 2.Department of Gastroenterology, the First Affiliated Hospital, Ganzhou, Jiangxi 341000
关键词:
粪菌移植 炎症性肠病 肠道菌群
Keywords:
fecal bacteria transplantation inflammatory bowel disease intestinal flora
分类号:
R-33
DOI:
10.3969/j.issn.1001-5779.2019.10.005
文献标志码:
A
摘要:
炎症性肠病(IBD)是免疫相关性肠道炎性反应性疾病,包括溃疡性结肠炎(UC)和克罗恩病(CD),发病机制复杂,涉及环境、生活方式、饮食、遗传、肠道菌群等多种致病相关因素,尽管IBD是多种因素介导的疾病,但越来越多的证据表明肠道菌群紊乱被认为是IBD发病的重要因素。因此恢复健康肠道菌群对治疗IBD有重要意义。近年来多项研究表明粪菌移植(fecal microbial transplantation,FMT)似乎非常有希望治疗或诱导IBD症状的缓解。本文就FMT的研究现状及其在IBD治疗中的应用作一综述。
Abstract:
Inflammatory bowel disease(IBD)is an immune-related intestinal inflammatory disease,Includes ulcerative colitis(UC)and Crohn's disease(CD),The pathogenesis is complex, involving various pathogenic factors such as environment, lifestyle, diet, genetics, and intestinal flora.Although IBD is a multifactorially mediated disease, there are increasing evidences that intestinal flora disorders are considered to be important factors in the pathogenesis of IBD.Therefore, restoring healthy intestinal flora is important for the treatment of IBD.In recent years, several studies have shown that fecal microbial transplantation(FMT)appears to be very promising for the treatment or induction of remission of IBD symptoms.This article reviews the current research status of FMT and its application in the treatment of IBD.

参考文献/References:

[1] Molodecky NA, Soon IS, Rabi DM, et al.Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review[J].Gastroenterology, 2012, 142(1): 46-54.
[2] Sales-Campos H, Basso PJ, Alves VB, et al.Classical and recent advances in the treatment of inflammatory bowel diseases[J].Braz J Med Biol Res, 2015, 48(2):96-107.
[3] D'haens GR, Jobin C.Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection[J].Gastroenterology, 2019, 19(3):894-901.
[4] Mullish BH, Quraishi MN, Segal JP, et al.The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology(BSG)and Healthcare Infection Society(HIS)guidelines[J].Gut, 2018, 67(11): 1920-1941.
[5] Kelly BJ, Tebas P.Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection[J].Chest, 2018, 153(1):266-277.
[6] Khan MY, Dirweesh A, Khurshid T, et al.Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol, 2018, 30(11): 1309-1317.
[7] Vermeire S, Joossens M, Verbeke K, et al.Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease[J].J Crohns Colitis, 2016, 10(4): 387-94.
[8] Paramsothy S, Borody T J, Lin E, et al.Donor Recruitment for Fecal Microbiota Transplantation[J].Inflamm Bowel Dis, 2015, 21(7): 1600-6.
[9] Terveer EM, Van Beurden YH, Goorhuis A, et al.How to: Establish and run a stool bank[J].Clin Microbiol Infect, 2017, 23(12): 924-930.
[10] Cammarota G, Ianiro G, Tilg H, et al.European consensus conference on faecal microbiota transplantation in clinical practice[J].Gut, 2017, 66(4): 569-580.
[11] Tang G, Yin W, Liu W.Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?[J].Diagn Microbiol Infect Dis, 2017, 88(4): 322-329.
[12] Lee CH, Steiner T, Petrof EO, et al.Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial[J].Jama, 2016, 315(2): 142-9.
[13] Jiang ZD, Ajami NJ, Petrosino J F, et al.Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection-fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy[J].Aliment Pharmacol Ther, 2017, 45(7): 899-908.
[14] Staley C, Hamilton MJ, Vaughn BP, et al.Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study[J].Am J Gastroenterol, 2017, 112(6): 940-947.
[15] Gweon TG, Kim J, Lim CH, et al.Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe Complicated Clostridium difficile Infection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country[J].Gastroenterol Res Pract, 2016, 2016: 2687605.
[16] Bhutiani N, Schucht JE, Miller KR, et al.Technical Aspects of Fecal Microbial Transplantation(FMT)[J].Curr Gastroenterol Rep, 2018, 20(7): 30.
[17] Konig J, Siebenhaar A, Hogenauer C, et al.Consensus report: faecal microbiota transfer-clinical applications and procedures[J].Aliment Pharmacol Ther, 2017, 45(2): 222-239.
[18] Jiang ZD, Jenq RR, Ajami NJ, et al.Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial[J].PLoS One, 2018, 13(11): e0205064.
[19] Kao D, Roach B, Silva M, et al.Effect of Oral Capsule-vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection:A Randomized Clinical Trial[J].Jama, 2017, 318(20):1985-1993.
[20] Shen ZH, Zhu CX, Quan YS, et al.Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation[J].World J Gastroenterol, 2018, 24(1): 5-14.
[21] Paramsothy S, Nielsen S, Kamm MA,et al.Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis[J].Gastroenterology,2019,156(5):1440-1454.
[22] Marchesi JR, Adams DH, Fava F, et al.The gut microbiota and host health: a new clinical frontier[J].Gut, 2016, 65(2): 330-9.
[23] Moayyedi P, Surette MG, Kim PT, et al.Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial[J].Gastroenterology, 2015, 149(1): 102-109.
[24] Rossen NG, Fuentes S, Van Der Spek MJ, et al.Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis[J].Gastroenterology, 2015, 149(1): 110-118.
[25] Paramsothy S, Kamm MA, Kaakoush NO, et al.Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial[J].Lancet, 2017, 389(10075): 1218-1228.
[26] Costello SP, Hughes PA, Waters O, et al.Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial[J].Jama, 2019, 321(2): 156-164.
[27] Sood A, Mahajan R, Singh A, et al.Role of Fecal Microbiota Transplantation for Maintenance of Remission in Patients with Ulcerative Colitis: A Pilot Study[J].J Crohns Colitis, 2019, 13(10):1-7.
[28] Chen T, Zhou Q, Zhang D, et al.Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease:A Systematic Review and Meta-Analysis of Cohort Studies[J].J Crohns Colitis, 2018, 12(6):710-717.
[29] Vaughn BP, Vatanen T, Allegretti JR, et al.Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease[J].Inflamm Bowel Dis, 2016, 22(9): 2182-90.
[30] Cui B, Feng Q, Wang H, et al.Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results[J].J Gastroenterol Hepatol, 2015, 30(1): 51-8.
[31] Paramsothy S, Paramsothy R, Rubin DT, et al.Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis[J].J Crohns Colitis, 2017, 11(10): 1180-1199.
[32] Narula N, Kassam Z, Yuan Y, et al.Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis[J].Inflamm Bowel Dis, 2017, 23(10): 1702-1709.
[33] Costello SP, Soo W, Bryant RV, et al.Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis[J].Aliment Pharmacol Ther, 2017, 46(3):213-224.
[34] Fang H, Fu L, Wang J.Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis[J].Biomed Res Int, 2018, 2018: 8941340.
[35] Jeon SR, Chai J, Kim C, et al.Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation[J].Curr Infect Dis Rep, 2018, 20(8): 21.
[36] Wang H, Cui B, Li Q, et al.The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study[J].Adv Ther, 2018, 35(11): 1935-1944.
[37] Ohkusa T, Koido S, Nishikawa Y, et al.Gut Microbiota and Chronic Constipation: A Review and Update[J].Front Med(Lausanne), 2019, 6: 19.
[38] Gundling F, Roggenbrod S, Schleifer S, et al.Patient perception and approval of faecal microbiota transplantation(FMT)as an alternative treatment option for obesity[J].Obes Sci Pract, 2019, 5(1): 68-74.
[39] Wu X, Zhang T, Chen X, et al.Microbiota transplantation: Targeting cancer treatment[J].Cancer Lett, 2019, 452: 144-151.
[40] Kurokawa S, Kishimoto T, Mizuno S, et al.The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study[J].J Affect Disord,2018,235:506-512.

相似文献/References:

[1]谢 华,何良梅,刘 瑶,等.肠道菌群与炎症性肠病[J].赣南医学院学报,2017,37(04):659.[doi:10.3969/j.issn.1001-5779.2017.04.050]
 XIE Hua,HE Liang-mei,LIU Yao,et al.Gut Microbiota and Inflammatory Bowel Diseases[J].,2017,37(10):659.[doi:10.3969/j.issn.1001-5779.2017.04.050]

备注/Memo

备注/Memo:
通信作者:吴雄健,男,博士,副主任医师,副教授,硕士生导师,研究方向:消化系疾病的基础与临床研究。E-mail:wuxj78@126.com
更新日期/Last Update: 2019-11-20